Try Fund Library Premium
For Free with a 30 day trial!
Global Equity
Click for more information on Fundata’s FundGrade.
|
NAVPS (02-13-2026) |
$14.56 |
|---|---|
| Change |
$0.02
(0.16%)
|
As at January 31, 2026
Inception Return (October 15, 2019): 10.89%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 2.87% | 2.04% | 7.58% | 2.87% | 6.86% | 16.28% | 14.66% | 10.04% | 10.80% | 11.01% | - | - | - | - |
| Benchmark | 2.09% | 0.95% | 10.80% | 2.09% | 14.53% | 22.02% | 19.47% | 13.40% | 13.11% | 13.15% | 13.63% | 11.67% | 12.63% | 12.43% |
| Category Average | 1.52% | 0.71% | 7.65% | 1.52% | 9.65% | 16.37% | 14.53% | 9.47% | 9.76% | 9.98% | 10.59% | 8.73% | 9.66% | 9.55% |
| Category Rank | 26 / 90 | 44 / 90 | 47 / 88 | 26 / 90 | 59 / 84 | 37 / 74 | 32 / 67 | 33 / 60 | 28 / 55 | 21 / 48 | - | - | - | - |
| Quartile Ranking | 2 | 2 | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | - | - | - | - |
| Return % | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 0.94% | -2.22% | -2.51% | 3.20% | 2.16% | -2.09% | 3.09% | 1.52% | 0.75% | 2.48% | -3.21% | 2.87% |
| Benchmark | -1.04% | -4.18% | -2.97% | 5.37% | 3.64% | 2.87% | 1.95% | 4.75% | 2.78% | -0.21% | -0.91% | 2.09% |
13.78% (November 2020)
-9.13% (March 2020)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | 6.47% | 14.10% | -6.68% | 14.90% | 20.50% | 10.99% |
| Benchmark | 5.18% | 16.29% | -1.79% | 21.41% | 13.15% | 17.62% | -12.64% | 19.37% | 26.84% | 16.60% |
| Category Average | 3.86% | 14.23% | -5.38% | 19.94% | 11.73% | 16.21% | -13.86% | 15.08% | 20.13% | 12.89% |
| Quartile Ranking | - | - | - | - | 3 | 3 | 2 | 2 | 2 | 3 |
| Category Rank | - | - | - | - | 27/ 48 | 41/ 55 | 21/ 59 | 32/ 65 | 31/ 73 | 53/ 83 |
20.50% (2024)
-6.68% (2022)
AA&A Global Equity Value Fund Series F
Median
Other - Global Equity
| Standard Deviation | 9.75% | 11.50% | - |
|---|---|---|---|
| Beta | 0.73% | 0.76% | - |
| Alpha | 0.01% | 0.01% | - |
| Rsquared | 0.47% | 0.56% | - |
| Sharpe | 1.07% | 0.71% | - |
| Sortino | 2.16% | 1.14% | - |
| Treynor | 0.14% | 0.11% | - |
| Tax Efficiency | 81.18% | 80.16% | - |
| Volatility |
|
|
- |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 8.38% | 9.75% | 11.50% | - |
| Beta | 0.50% | 0.73% | 0.76% | - |
| Alpha | 0.00% | 0.01% | 0.01% | - |
| Rsquared | 0.39% | 0.47% | 0.56% | - |
| Sharpe | 0.53% | 1.07% | 0.71% | - |
| Sortino | 0.71% | 2.16% | 1.14% | - |
| Treynor | 0.09% | 0.14% | 0.11% | - |
| Tax Efficiency | 96.59% | 81.18% | 80.16% | - |
| Start Date | October 15, 2019 |
|---|---|
| Instrument Type | Exempt Product |
| Share Class | Fee Based Advice |
| Legal Status | - |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | $145 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| ALD400 |
The investment objective of the Fund is to maximize capital appreciation and achieve a superior long-term rate of return from investing in the shares of publicly traded companies. The Fund aims to achieve higher returns than its benchmark while minimizing risk over a full market cycle.
-
| Portfolio Manager |
Allard, Allard & Associates Inc. |
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
- |
|---|---|
| Custodian |
Natcan Trust Company |
| Registrar |
- |
| Distributor |
- |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | No |
| PAC Initial Investment | - |
| PAC Subsequent | - |
| SWP Allowed | No |
| SWP Min Balance | - |
| SWP Min Withdrawal | - |
| MER | - |
|---|---|
| Management Fee | 1.00% |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 0.00% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!